{"transactions":[{"id":749716,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:08:50.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."}],"balance_after":16133,"derivative":{"exercise_price":3.77,"exercise_date":"2027-01-20","expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":16133},"source":{"system":"sec-edgar","filing":"0001816242-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000181624226000002/ownership.xml","form_type":"4"}},{"id":749715,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:08:50.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":22214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 22,990 of the Issuer's CDIs. The Reporting Person's 22,990 CDIs translate into 4,598 of the shares of Common Stock set forth above."}],"balance_after":69148,"source":{"system":"sec-edgar","filing":"0001816242-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000181624226000002/ownership.xml","form_type":"4"}},{"id":1121477,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T20:41:59.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":4295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On January 6, 2025, the Board of Directors approved a grant of 4,295 options to acquire 4,295 shares of Common Stock to each of its non-executive directors, with a grant date of January 21, 2025 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $8.73. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."}],"balance_after":4295,"derivative":{"exercise_price":8.73,"exercise_date":"2026-01-21","expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":4295},"source":{"system":"sec-edgar","filing":"0000950170-25-082422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017025082422/ownership.xml","form_type":"4"}},{"id":1121476,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:41:59.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 21, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 22,990 of the Issuer's CDIs. The Reporting Person's 22,990 CDIs translate into 4,598 of the shares of Common Stock set forth above."}],"balance_after":46934,"source":{"system":"sec-edgar","filing":"0000950170-25-082422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017025082422/ownership.xml","form_type":"4"}},{"id":1291935,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-29T21:57:48.000Z","date":"2024-12-09","kind":"purchase","planned":false,"acquired":true,"shares":486,"price":13.15,"value":6390.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 2,430 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of the Issuer's common stock and have all the rights and privileges of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price was converted from A$4.11, using the exchange rate as in effect on the date of the transaction, and reflects the 5:1 consolidation ratio applied in converting CDIs to shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 22,990 of the Issuer's CDIs. The Reporting Person's 22,990 CDIs translate into 4,598 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes unvested RSUs."}],"balance_after":36912,"source":{"system":"sec-edgar","filing":"0000950170-25-010560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017025010560/ownership.xml","form_type":"4"}},{"id":1488564,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-06T23:36:12.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3943,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3943,"derivative":{"exercise_price":9.51,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-24-070118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017024070118/ownership.xml","form_type":"4"}},{"id":1488563,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T23:36:12.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 20,560 of the Issuer's CDIs. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above."}],"balance_after":36426,"source":{"system":"sec-edgar","filing":"0000950170-24-070118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000095017024070118/ownership.xml","form_type":"4"}},{"id":1862565,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-08T20:34:29.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":2646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person may elect to acquire the Issuer's CHESS Depositary Interests (\"CDIs\") in place of common stock upon vesting of a Restricted Stock Unit (\"RSU\") or exercise of a Stock Option. CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.  Five CDIs are equivalent to one share of common stock and have all the rights and privileges of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These Stock Options vest on the date 12 months following the grant date."}],"balance_after":2646,"derivative":{"exercise_price":14.17,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":2646},"source":{"system":"sec-edgar","filing":"0001209191-23-035434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000120919123035434/doc4.xml","form_type":"4"}},{"id":1862564,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T20:34:29.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":6175,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person may elect to acquire the Issuer's CHESS Depositary Interests (\"CDIs\") in place of common stock upon vesting of a Restricted Stock Unit (\"RSU\") or exercise of a Stock Option. CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.  Five CDIs are equivalent to one share of common stock and have all the rights and privileges of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 20,560 of the Issuer's CDIs. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above."}],"balance_after":27226,"source":{"system":"sec-edgar","filing":"0001209191-23-035434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000120919123035434/doc4.xml","form_type":"4"}},{"id":2086605,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-12-14T22:24:12.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":5395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These Stock Options vest on the date 12 months following the grant date."}],"balance_after":5395,"derivative":{"exercise_price":6.95,"expiration_date":"2032-12-12","underlying":"Common Stock","underlying_shares":5395},"source":{"system":"sec-edgar","filing":"0001209191-22-061281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000120919122061281/doc4.xml","form_type":"4"}},{"id":2086604,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-14T22:24:12.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":12589,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,560 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."}],"balance_after":21051,"source":{"system":"sec-edgar","filing":"0001209191-22-061281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000120919122061281/doc4.xml","form_type":"4"}},{"id":2458694,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-12-27T21:31:10.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These Stock Options vest on the date 12 months following the grant date."}],"balance_after":2550,"derivative":{"exercise_price":12.18,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":2550},"source":{"system":"sec-edgar","filing":"0001209191-21-071257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000120919121071257/doc4.xml","form_type":"4"}},{"id":2458693,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-27T21:31:10.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":4350,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,560 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested RSUs."}],"balance_after":8462,"source":{"system":"sec-edgar","filing":"0001209191-21-071257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000120919121071257/doc4.xml","form_type":"4"}},{"id":2563161,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":41372,"kind":"person","name":"Crowe Suzanne","position":1,"cik":"0001816242","reported_name":"Crowe Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-21T20:30:30.000Z","date":"2021-09-20","kind":"purchase","acquired":true,"shares":1066,"price":17.08,"value":18207.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 5,330 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of the Issuer's common stock and have all the rights and privileges of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price was converted from A$4.72, using the exchange rate as in effect on the date of the transaction, and reflects the 5:1 consolidation ratio applied in converting CDIs to shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person holds 20,560 CDIs, which translate into the 4,112 shares of common stock set forth above."}],"balance_after":4112,"source":{"system":"sec-edgar","filing":"0001209191-21-057037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816242/000120919121057037/doc4.xml","form_type":"4"}}]}